CONMED Corp — Director's Dealing 2013

Aug 2, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-08-01

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-01	Common Stock	M	10000	$29.92	Acquired	16417	Direct
2013-08-01	Common Stock	F	9401	$33.03	Disposed	7016	Direct
2013-08-01	Common Stock	M	2000	$26.69	Acquired	9016	Direct
2013-08-01	Common Stock	F	1757	$33.03	Disposed	7259	Direct
2013-08-01	Common Stock	M	2000	$27.63	Acquired	9259	Direct
2013-08-01	Common Stock	F	1793	$33.03	Disposed	7466	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-01	Sars (Stock Appreciation Rights)	$29.92	M	10000	Disposed	2017-05-17	Common Stock (10000)	Direct
2013-08-01	Sars (Stock Appreciation Rights)	$26.69	M	2000	Disposed	2018-06-01	Common Stock (2000)	Direct
2013-08-01	Sars (Stock Appreciation Rights)	$27.63	M	2000	Disposed	2021-06-01	Common Stock (2000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.